HIKMA Pharmaceuticals PLC

Remuneration Information • Apr 3, 2023

National Storage Mechanism | Additional information

RNS Number : 1243V

Hikma Pharmaceuticals Plc

03 April 2023

Hikma Pharmaceuticals PLC

Block Listing Six Monthly Return

Date: 3 April 2023

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
Period of return	From: 1 October 2022	To:	31 March 2023
Balance of unallotted securities under scheme(s) from previous return:	SOP: 792,700 Ordinary Shares of 10 pence
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	SOP: 0 Ordinary Shares of 10 pence
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	SOP: 0 Ordinary Shares of 10 pence
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:	SOP: 792,700 Ordinary Shares of 10 pence
The Hikma Pharmaceuticals plc 2004 Stock Option Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form.

Name of contact:	Hussein Arkhagha
Telephone number of contact:	+44(0)20 7399 2760

Block Listing Six Monthly Return

Date: 3 April 2023

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
Period of return	From: 1 October 2022	To:	31 March 2023
Balance of unallotted securities under scheme(s) from previous return:	LTIP: 57,502 Ordinary Shares of 10 pence
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	LTIP: 0 Ordinary Shares of 10 pence
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	LTIP: 0 Ordinary Shares of 10 pence
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:	LTIP: 57,502 Ordinary Shares of 10 pence
The Hikma Pharmaceuticals plc 2005 Long-Term Incentive Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form.

Name of contact:	Hussein Arkhagha
Telephone number of contact:	+44(0)20 7399 2760

Block Listing Six Monthly Return

Date: 3 April 2023

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")
Period of return	From: 1 October 2022	To:	31 March 2023
Balance of unallotted securities under scheme(s) from previous return:	2009 MIP: 0 Ordinary Shares of 10 pence
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	2009 MIP: 0 Ordinary Shares of 10 pence
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	2009 MIP: 0 Ordinary Shares of 10 pence
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:	2009 MIP: 0 Ordinary Shares of 10 pence
The Hikma Pharmaceuticals plc 2009 Management Incentive Plan has expired. No further shares may be issued under the block listing and no further block listing returns will be made in respect of this expired Plan; therefore, the block listing is hereby cancelled. In accordance with LR3.5.6R, a final block listing return in respect of this block listing is set out above in the prescribed form.

Name of contact:	Hussein Arkhagha
Telephone number of contact:	+44(0)20 7399 2760

Block Listing Six Monthly Return

Date: 3 April 2023

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")
Period of return	From: 1 October 2022	To:	31 March 2023
Balance of unallotted securities under scheme(s) from previous return:	2018 MIP: 414,112 Ordinary Shares of 10 pence EIP: 354,962 Ordinary Shares of 10 pence
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	The Plans: 1,200,000 Ordinary Shares of 10 pence
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	2018 MIP: 294,737 Ordinary Shares of 10 pence EIP: 176,424 Ordinary Shares of 10 pence
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:	The Plans: 1,497,913 Ordinary Shares of 10 pence

Name of contact:	Hussein Arkhagha
Telephone number of contact:	+44(0)20 7399 2760

LEI: 549300BNS685UXH4JI75

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRUPUAPCUPWURW